about
Pertussis: Microbiology, Disease, Treatment, and Prevention.Albumin, in the Presence of Calcium, Elicits a Massive Increase in Extracellular Bordetella Adenylate Cyclase Toxin.Use of a Toxin Neutralization Assay To Characterize the Serologic Response to Adenylate Cyclase Toxin after Infection with Bordetella pertussisReview of the neutrophil response to Bordetella pertussis infection.Asymptomatic transmission and the resurgence of Bordetella pertussis.Universal tetanus, diphtheria, acellular pertussis (Tdap) vaccination of adults: What Canadian health care providers know and need to know.Comparison of Three Whole-Cell Pertussis Vaccines in the Baboon Model of PertussisA Bordetella pertussis proteoliposome induces protection in mice without affecting the immunogenicity of diphtheria and tetanus toxoids in a trivalent formulation.Alternatives to HIST for acellular pertussis vaccines: progress and challenges in replacement.Evaluation of outbreak response immunization in the control of pertussis using agent-based modelingThe baboon model of pertussis: effective use and lessons for pertussis vaccines.Investigating pertussis toxin and its impact on vaccination.Predicting future trends in the burden of pertussis in the 21st century: implications for infant pertussis and the success of maternal immunization.No pain no gain? Adjuvant effects of alum and monophosphoryl lipid A in pertussis and HPV vaccines.What Is Wrong with Pertussis Vaccine Immunity? The Problem of Waning Effectiveness of Pertussis Vaccines.The relationship between mucosal immunity, nasopharyngeal carriage, asymptomatic transmission and the resurgence of Bordetella pertussis.Pertussis: pertussis control strategies and the options for improving current vaccines.Whither pertussis?On the Role of Different Age Groups and Pertussis Vaccines During the 2012 Outbreak in Wisconsin.
P2860
Q30251684-5F5E3F6F-9E7D-4190-8609-BB1B2F72451AQ30252682-381D0285-1199-49AF-A969-9F57BA34BCAEQ30275563-83C1BF17-1C6C-4088-9887-87A059F179FFQ30278579-0889513A-1C9A-4576-8AFE-DF53BC19F365Q35672136-C7E61707-416B-4A2F-A394-3549F5786221Q36256236-43927959-D1C5-45B9-95B6-460927F02444Q36457650-7339C61E-8324-4416-A674-F8AF8ED87F62Q37143652-A0DACF45-8727-4AF9-94B4-38D979431232Q37167460-305DCCD8-CFB0-477D-969A-C28C6BB9C60CQ37195771-96811B89-F1F2-4605-8210-F8792BB9860AQ38245642-483D9ADA-7C9E-4FE0-89A1-A536E2B2F76AQ38358628-8E21FCBD-A0CD-4C3F-B8B1-52D038E83EA4Q38630803-3081E2CF-0343-4F78-B2C0-5FBD58BDB5CCQ39447985-6C3FE977-9190-4ACD-B64C-42F0FFFF1CA1Q40295958-A4432945-B6C8-49C3-BE22-41F643285119Q41588991-B070F3A4-4757-45B7-AFF1-EC3D2A69517EQ44324857-46F92B19-2EC7-44B0-A0DA-93CF2956CA29Q45204641-8EFF0BB9-2F88-499A-97B2-C7BC0D7A59D9Q55383986-F9690249-0160-4BB9-AED4-894AC6BF844B
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Possible options for new pertussis vaccines.
@en
type
label
Possible options for new pertussis vaccines.
@en
prefLabel
Possible options for new pertussis vaccines.
@en
P2860
P356
P1476
Possible options for new pertussis vaccines.
@en
P2093
Bruce D Meade
P2860
P356
10.1093/INFDIS/JIT531
P407
P478
209 Suppl 1
P577
2014-04-01T00:00:00Z